Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for general anesthesia in geriatric orthopedic surgery
ChiCTR2300072351Phase 4Not yet recruiting
- Sponsor
- Xi'an International Medical Center Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam, sevoflurane and propofol in postoperative delirium (POD) (3 arms), sponsored by Xi'an International Medical Center Hospital. Primary endpoint: Postoperative delirium. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
remimazolamsevofluranepropofol
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2300072351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072351.